CD34 and Parkinson disease: The humanized CD34+ mice, along with age-matched C57BL/6 mice, were injected with MPTP to produce PD-like symptoms with or without intravenous injection of the immunosuppressive calcineurin/NFAT inhibitor drug, FK506, as a neuroprotectant.